Security key
76155X100
Revolution Medicines, Inc. - Common Stock (RVMD)
CUSIP: 76155X100
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 199,316,245
- Total 13F shares
- 193,048,484
- Share change
- +15,551,010
- Total reported value
- $8,445,124,761
- Put/Call ratio
- 115%
- Price per share
- $43.74
- Number of holders
- 278
- Value change
- +$672,301,180
- Number of buys
- 166
- Number of sells
- 87
Report period
Q4 2024
Institutions
278
Top holders
10
RVMD full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Revolution Medicines, Inc. SEC filings
Revolution Medicines, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 76155X100
Recent filing periods:
Top shareholders of RVMD - Revolution Medicines, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
7.5%
|
14,911,373
|
$676,230,767 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
7%
|
13,866,858
|
$628,862,011 | — | 30 Sep 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
5.7%
|
11,401,394
|
$517,053,219 | — | 30 Sep 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
3.8%
|
7,569,090
|
$343,258,232 | — | 30 Sep 2024 | |
| Nextech Invest Ltd. |
13F
|
Company |
3.2%
|
6,296,740
|
$285,557,159 | — | 30 Sep 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3.1%
|
6,137,244
|
$278,279,759 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
2.9%
|
5,875,893
|
$266,471,747 | — | 30 Sep 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
2.7%
|
5,314,089
|
$240,993,936 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.6%
|
5,279,584
|
$239,429,134 | — | 30 Sep 2024 | |
| Bellevue Group AG |
13F
|
Company |
2.4%
|
4,871,360
|
$220,916,176 | — | 30 Sep 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
2.1%
|
4,279,464
|
$194,073,692 | — | 30 Sep 2024 | |
| Alphabet Inc. |
13F
|
Company |
2.1%
|
4,256,175
|
$193,017,536 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.1%
|
4,137,920
|
$187,654,681 | — | 30 Sep 2024 | |
| Casdin Capital, LLC |
13F
|
Company |
2.1%
|
4,114,283
|
$186,582,734 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
3,627,025
|
$164,517,278 | — | 30 Sep 2024 | |
| BVF INC/IL |
13F
|
Company |
1.7%
|
3,478,612
|
$157,755,054 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.7%
|
3,433,713
|
$155,718,885 | — | 30 Sep 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.5%
|
2,912,692
|
$132,090,582 | — | 30 Sep 2024 | |
| a16z Capital Management, L.L.C. |
13F
|
Company |
1.4%
|
2,748,523
|
$124,645,518 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.2%
|
2,354,602
|
$106,781,202 | — | 30 Sep 2024 | |
| Holocene Advisors, LP |
13F
|
Company |
1.1%
|
2,149,561
|
$97,482,591 | — | 30 Sep 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.92%
|
1,832,021
|
$83,082,000 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.88%
|
1,763,117
|
$79,957,356 | — | 30 Sep 2024 | |
| NORGES BANK |
13F
|
Company |
0.88%
|
1,746,601
|
$79,208,355 | — | 30 Sep 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.83%
|
1,651,805
|
$74,909,357 | — | 30 Sep 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.75%
|
1,485,422
|
$67,363,883 | — | 30 Sep 2024 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.67%
|
1,332,812
|
$60,443,024 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.66%
|
1,311,288
|
$59,466,911 | — | 30 Sep 2024 | |
| Logos Global Management LP |
13F
|
Company |
0.6%
|
1,200,000
|
$54,420,000 | — | 30 Sep 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.53%
|
1,064,999
|
$48,297,706 | — | 30 Sep 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.51%
|
1,009,945
|
$45,801,006 | — | 30 Sep 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
0.5%
|
997,455
|
$45,234,584 | — | 30 Sep 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.4%
|
790,000
|
$35,826,500 | — | 30 Sep 2024 | |
| Siren, L.L.C. |
13F
|
Individual |
0.38%
|
753,601
|
$34,175,805 | — | 30 Sep 2024 | |
| Finepoint Capital LP |
13F
|
Company |
0.37%
|
731,960
|
$33,194,386 | — | 30 Sep 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.35%
|
704,584
|
$31,952,884 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.33%
|
652,818
|
$29,605,321 | — | 30 Sep 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.29%
|
577,408
|
$26,185,478 | — | 30 Sep 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.28%
|
563,782
|
$25,566,369 | — | 30 Sep 2024 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.27%
|
540,673
|
$24,519,521 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.27%
|
532,310
|
$24,140,256 | — | 30 Sep 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
523,051
|
$23,720,363 | — | 30 Sep 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.26%
|
517,994
|
$23,491,028 | — | 30 Sep 2024 | |
| MIC Capital Management UK LLP |
13F
|
Company |
0.26%
|
508,569
|
$23,063,604 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.23%
|
459,337
|
$20,830,933 | — | 30 Sep 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.22%
|
437,750
|
$19,851,963 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.21%
|
428,118
|
$19,415,151 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.2%
|
394,473
|
$17,889,351 | — | 30 Sep 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.18%
|
350,000
|
$15,872,500 | — | 30 Sep 2024 | |
| Mass General Brigham, Inc |
13F
|
Company |
0.17%
|
338,191
|
$15,336,962 | — | 30 Sep 2024 |
Institutional Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q4 2024
As of 31 Dec 2024,
Revolution Medicines, Inc. - Common Stock (RVMD) was held by
278 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
193,048,484 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., FARALLON CAPITAL MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, JANUS HENDERSON GROUP PLC, BAKER BROS. ADVISORS LP, Nextech Invest Ltd., FMR LLC, Paradigm Biocapital Advisors LP, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
281
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
252
Q4 2024 holders
278
Holder diff
26
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.